Exchange: NASDAQ·Updated 10:00 AM EDT
ARDX logo

ARDXArdelyx Inc

$5.21
$0.09
(1.70%)
Today
EarningsAug 3
Mkt Cap$1.31B
Vol136,688.00
News
all
press releases
ARDX Stock Tumbles As Xphozah Loses Final Medicare Reimbursement Battle
The U.S. Court of Appeals for the D.C. Circuit said federal law prevents judges from reviewing Medicare’s decision to include certain kidney drugs in the dialysis payment bundle.
Stocktwits
News Placeholder
More News
News Placeholder
Aquestive Therapeutics (AQST) Moves 6.6% Higher: Will This Strength Last?
Aquestive Therapeutics (AQST) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
Zacks
News Placeholder
Ardelyx Stock Up 70%: What to Know About This $490,000 Insider Transaction
Key PointsAccording to an SEC filing, an executive at Ardelyx reported selling 81,898 directly held Common Stock shares on June 18, 2026, generating a transaction value of $490,000...
Nasdaq News: Markets
News Placeholder
ARDX Edges Up After Hours On IBSRELA Momentum And Profitability ‘Right Around The Corner’
CFO said at a conference that profitability is “right around the corner,” though the company is waiting for more top-line certainty before formal guidance.
Stocktwits
News Placeholder
Should You Buy Ardelyx (ARDX)?
Should You Buy Ardelyx (ARDX...
Yahoo! Finance: News
News Placeholder
Ardelyx (NASDAQ:ARDX) Trading Up 7.4% - What's Next?
Ardelyx (NASDAQ:ARDX) Shares Up 7.4% - What's Next...
MarketBeat
News Placeholder
FY2030 Earnings Forecast for Ardelyx Issued By HC Wainwright
Ardelyx, Inc. (NASDAQ:ARDX - Free Report) - Research analysts at HC Wainwright cut their FY2030 earnings per share estimates for Ardelyx in a research note issued on Friday, May 1st. HC Wainwright analyst M. Caufield now anticipates that the biopharmaceutical company will earn $1.60 per share for th...
MarketBeat
News Placeholder
AIGH Capital Management LLC Purchases 951,500 Shares of Ardelyx, Inc. $ARDX
AIGH Capital Management LLC lifted its position in Ardelyx, Inc. (NASDAQ:ARDX - Free Report) by 479.3% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 1,150,000 shares of the biopharmaceutical company's...
MarketBeat
News Placeholder
Ardelyx (NASDAQ:ARDX) Shares Gap Down After Earnings Miss
Ardelyx (NASDAQ:ARDX) Shares Gap Down Following Weak Earnings...
MarketBeat
News Placeholder
Ardelyx (NASDAQ:ARDX) Posts Quarterly Earnings Results, Misses Expectations By $0.03 EPS
Ardelyx (NASDAQ:ARDX - Get Free Report) issued its quarterly earnings results on Thursday. The biopharmaceutical company reported ($0.15) earnings per share for the quarter, missing the consensus...
MarketBeat
<
1
2
...
>

Advertisement|Remove ads.